Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SMR3B |
| Upstream (Parents) |
|---|
| (<<) PGF → SMR3B |
| (<<) SIN3B → SMR3B |
| (<<) COL6A2 → SMR3B |
| (<<) DKK3 → SMR3B |
| (<<) ISLR → SMR3B |
| Downstream (Children) |
|---|
| SMR3B → YSK4 (>>) |
| SMR3B → PCDHA9 (>>) |
| SMR3B → BAI3 (>>) |
| SMR3B → NXF2B///NXF2 (>>) |
| SMR3B → NR5A1 (>>) |
| SMR3B → GJC1 (>>) |
| SMR3B → POU3F2 (>>) |
| SMR3B → ZNF222 (>>) |
| SMR3B → RBMY1J///RBMY1E///RBMY1D///RBMY1B///RBMY1F///RBMY3AP///RBMY1H///RBMY1A1 (>>) |
| SMR3B → CCL17 (>>) |
